171 related articles for article (PubMed ID: 31567996)
1. High-throughput autoantibody analysis in malignant pleural effusion and tuberculosis pleural effusion.
Yi F; Zhang X
Medicine (Baltimore); 2019 Sep; 98(38):e17253. PubMed ID: 31567996
[TBL] [Abstract][Full Text] [Related]
2. Pleural IFN-γ release assay combined with biomarkers distinguished effectively tuberculosis from malignant pleural effusion.
Tang Y; Zhang J; Huang H; He X; Zhang J; Ou M; Li G; Zeng C; Ye T; Ren L; Liu Y; Zhang G
BMC Infect Dis; 2019 Jan; 19(1):55. PubMed ID: 30651075
[TBL] [Abstract][Full Text] [Related]
3. A combination of the QuantiFERON-TB Gold In-Tube assay and the detection of adenosine deaminase improves the diagnosis of tuberculous pleural effusion.
Liu Y; Ou Q; Zheng J; Shen L; Zhang B; Weng X; Shao L; Gao Y; Zhang W
Emerg Microbes Infect; 2016 Aug; 5(8):e83. PubMed ID: 27485497
[TBL] [Abstract][Full Text] [Related]
4. Potential diagnostic value of serum/pleural fluid IL-31 levels for tuberculous pleural effusion.
Gao Y; Ou Q; Wu J; Zhang B; Shen L; Chen S; Weng X; Zhang Y; Zhang W; Shao L
Sci Rep; 2016 Feb; 6():20607. PubMed ID: 26864868
[TBL] [Abstract][Full Text] [Related]
5. Differential diagnosis of tuberculous and malignant pleural effusions: comparison of the Th1/Th2 cytokine panel, tumor marker panel and chemistry panel.
Zhang J; Chen Y; He G; Jiang X; Chen P; Ouyang J
Scand J Clin Lab Invest; 2020 Jul; 80(4):265-270. PubMed ID: 32108543
[TBL] [Abstract][Full Text] [Related]
6. [Level of soluble programmed death ligand 1 in pleural effusion and peripheral blood of patients with tuberculous pleural effusion and its clinical implications].
Pan X; Xing Y; Shi M; Zhou T; Qian B; Chen Y
Zhonghua Yi Xue Za Zhi; 2014 May; 94(20):1543-6. PubMed ID: 25146741
[TBL] [Abstract][Full Text] [Related]
7. Monocytes subtypes from pleural effusion reveal biomarker candidates for the diagnosis of tuberculosis and malignancy.
Luo L; Deng S; Tang W; Hu X; Yin F; Ge H; Tang J; Liao Z; Feng J; Li X; Mo B
J Clin Lab Anal; 2022 Aug; 36(8):e24579. PubMed ID: 35819097
[TBL] [Abstract][Full Text] [Related]
8. Clinical value of haptoglobin and soluble CD163 testing for the differential diagnosis of tuberculous and malignant pleural effusions.
Gao J; Song L; Li D; Peng L; Ding H
Medicine (Baltimore); 2019 Oct; 98(42):e17416. PubMed ID: 31626097
[TBL] [Abstract][Full Text] [Related]
9. Pleural fluid adenosine deaminase to serum C-reactive protein ratio for diagnosing tuberculous pleural effusion.
Rabbi MF; Ahmed MN; Patowary MSA; Huq SR; Razzaque SMA; Arafat HM; Nahar T; Iktidar MA
BMC Pulm Med; 2023 Sep; 23(1):349. PubMed ID: 37715196
[TBL] [Abstract][Full Text] [Related]
10. Use of Platelet Parameters in the Differential Diagnosis of Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Tuberculous Pleural Effusion.
Ai L; Li J; Ye T; Wang W; Li Y
Dis Markers; 2022; 2022():5653033. PubMed ID: 35531478
[TBL] [Abstract][Full Text] [Related]
11. Predictive Factors and Treatment Outcomes of Tuberculous Pleural Effusion in Patients With Cancer and Pleural Effusion.
Lee J; Lee YD; Lim JK; Lee DH; Yoo SS; Lee SY; Cha SI; Park JY; Kim CH
Am J Med Sci; 2017 Aug; 354(2):125-130. PubMed ID: 28864369
[TBL] [Abstract][Full Text] [Related]
12. A meta-analysis of Th1 and Th2 cytokine profiles differentiating tuberculous from malignant pleural effusion.
Zeng Y; Wang L; Zhou H; Qi Y
Sci Rep; 2022 Feb; 12(1):2743. PubMed ID: 35177742
[TBL] [Abstract][Full Text] [Related]
13. Identification of differentially expressed miRNAs in differentiating benign from malignant pleural effusion.
Bao Q; Xu Y; Ding M; Chen P
Hereditas; 2020 Feb; 157(1):6. PubMed ID: 32102688
[TBL] [Abstract][Full Text] [Related]
14. Comparison of biochemical parameters and chemokine levels in pleural fluid between patients with anergic and non-anergic tuberculous pleural effusion.
Kim HJ; Ryu S; Choi SH; Seo H; Yoo SS; Lee SY; Cha SI; Park JY; Kim CH; Lee J
Tuberculosis (Edinb); 2020 Jul; 123():101940. PubMed ID: 32452425
[TBL] [Abstract][Full Text] [Related]
15. Predictive role of adenosine deaminase for differential diagnosis of tuberculosis and malignant pleural effusion in Turkey.
Yildiz PB; Yazar EE; Gorgun D; Secik F; Cakir G
Asian Pac J Cancer Prev; 2011; 12(2):419-23. PubMed ID: 21545206
[TBL] [Abstract][Full Text] [Related]
16. Clinical Value of Tumor Markers for Determining Cause of Pleural Effusion.
Gu Y; Zhai K; Shi HZ
Chin Med J (Engl); 2016 Feb; 129(3):253-8. PubMed ID: 26831224
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic role of interleukin -33 in the differentiation of pleural effusions especially tuberculous and malignant effusions.
Al-Aarag AH; Kamel MH; Abdelgawad ER; Abo-Youssef SM; Moussa HH; Elnaggar ME; Hendy RM; Diab KA
BMC Pulm Med; 2019 Jun; 19(1):114. PubMed ID: 31238901
[TBL] [Abstract][Full Text] [Related]
18. Novel clinical biomarkers in blood and pleural effusion for diagnosing patients with tuberculosis distinguishing from malignant tumor.
Wang J; Feng ZX; Ren T; Meng WY; Khan I; Fan XX; Pan HD; Liu L; Tang YJ; Yao XJ; Li RZ; Wang MF; Leung EL
Medicine (Baltimore); 2022 Oct; 101(41):e31027. PubMed ID: 36254028
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of superoxide dismutase in tuberculous and malignant pleural effusions.
Wang XF; Wu YH; Jiao J; Guan CP; Yang XG; Wang MS
Asian Pac J Cancer Prev; 2013; 14(2):821-4. PubMed ID: 23621245
[TBL] [Abstract][Full Text] [Related]
20. Activated partial thromboplastin time as a potential biomarker for the diagnosis of tuberculous pleural effusion.
Liang L; Li X; Liu B; Zhang Q; He X; Tan K; Rong F
Am J Med Sci; 2023 May; 365(5):437-442. PubMed ID: 36283425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
